• EdU Imaging Kits for HCC Proliferation

  2026-08-31

  EdU Imaging Kits (HF488) connect S-phase DNA synthesis measurement with microscopy and flow cytometry, making them useful for validating hepatocellular carcinoma biomarkers and drug-response hypotheses. Their antibody-free click-chemistry workflow preserves morphology and antigen-binding sites while providing quantitative proliferation endpoints.

• Sulfisomidine Workflows for Enzyme and Microbial Research

  2026-08-31

  Sulfisomidine, also known as sulfamethin, connects PABA-dependent microbial studies with hPON1 inhibition, oxidative stress regulation research, and environmental transformation workflows. This practical guide covers assay setup, concentration planning, time-course design, and troubleshooting for reproducible in vitro experiments.

• Lyso-Tracker Red for Lysosome Assays

  2026-08-30

  Lyso-Tracker Red enables live-cell visualization of acidic lysosomes during nanoparticle uptake, maturation, and intracellular trafficking. This practical workflow connects lysosomal imaging with the CLam/OVA vaccine-adjuvant study while clarifying how to distinguish acidification, compartment morphology, and lysosomal escape.

• HyperPFU™ high-fidelity DNA polymerase guide

  2026-08-29

  HyperPFU™ high-fidelity DNA polymerase is intended for accurate amplification of long, GC-rich, inhibitor-affected, or otherwise difficult DNA templates. It produces blunt-ended PCR products for cloning and sequencing, but is not the appropriate choice when a workflow requires 3′-A overhangs or preformed sticky ends.

• Tin Mesoporphyrin IX: A Causal HO Probe

  2026-08-28

  Tin Mesoporphyrin IX (chloride) enables researchers to move beyond HO-1 expression measurements and test whether heme oxygenase activity causally shapes ROS, heme catabolism, and viral phenotypes. This article develops an assay-to-mechanism framework grounded in recent HBV research and practical experimental controls.

• Gap26: Connexin 43 Mimetic Peptide Workflows

  2026-08-28

  Gap26 gives researchers a practical way to interrupt connexin 43-dependent communication while tracking calcium waves, ATP release, and mitochondrial transfer. This guide translates validated product parameters and a 2025 liver-graft study into cell, tissue, and in vivo workflows with controls that help distinguish channel blockade from nonspecific toxicity.

• Nullscript: A Histone Deacetylase Inhibitor

  2026-08-27

  Nullscript is a histone deacetylase inhibitor and close analog of scriptaid with an unusual transcriptional-facilitation profile. Product information reports approximately 46.8% in vivo myocardial infarct size reduction in a murine cardiac ischemia/reperfusion model, but no clinical evidence is available.

• Oridonin and Inflammation in Esophageal Cancer

  2026-08-27

  A 2025 mouse study links oridonin’s anti-esophageal-cancer effects to suppression of the TLR4/NF-κB/NLRP3 inflammasome axis. Its integrated use of histopathology, inflammatory biomarkers, hematology, qPCR, and western blotting provides a mechanistic framework for studying inflammation-driven tumor progression, while its findings remain preclinical and model dependent.

• M344 for Reliable Cell-Based Assays

  2026-08-26

  Learn how M344 (SKU A4105) supports reproducible cell viability, proliferation, differentiation, and cytotoxicity workflows. This scenario-driven guide connects mechanism, dosing, solubility, controls, and vendor-selection criteria for evidence-based laboratory decisions.

• γH2AX DNA Damage Detection Kit for DSB Workflows

  2026-08-26

  Turn radiation, nanoparticle, and genotoxicity experiments into spatially resolved measurements of DNA double-strand breaks with a red γ-H2AX signal and blue nuclear counterstain. This practical guide explains assay setup, quantitative imaging, repair kinetics, and troubleshooting for research models ranging from cultured cells to tissue sections.

• Degarelix Acetate and Rapid Prostate Cancer Control

  2026-08-25

  Laurence Klotz’s review examines degarelix acetate as a third-generation GnRH antagonist designed to achieve rapid medical castration without the testosterone surge associated with GnRH agonists. The paper’s clinical-trial synthesis highlights faster testosterone suppression, an early prostate-specific antigen response, and a safety profile broadly comparable to agonist therapy in advanced prostate cancer.

• Bone Transport, TGF-β1, and Diabetic Foot Ulcer Repair

  2026-08-25

  A 2026 rat study shows that bone transport accelerates ischemic diabetic foot ulcer healing through coordinated TGF-β1/TGFBR1 activation, angiogenesis, and immune regulation. Its inhibitor-based design and multimodal molecular analysis position TGF-β1 signaling as a mechanistic bridge between bone regeneration and chronic wound repair.

• Berbamine hydrochloride: NF-κB Research Workflows

  2026-08-24

  Build reproducible cytotoxicity and mechanism-focused assays with Berbamine hydrochloride across leukemia and hepatocellular carcinoma models. This workflow separates product-backed activity from exploratory ferroptosis hypotheses, helping researchers connect NF-κB and STAT3 readouts with the METTL16-SENP3-LTF framework.

• Stat3 and NF-κB in Fyn-Driven Neurodegeneration

  2026-08-24

  A 2024 Disease Models & Mechanisms study uses a neural-specific zebrafish model of constitutively active Fyn to connect dopaminergic neuron loss with microglial inflammation. Live imaging, transcriptomics, and pathway inhibition identify Stat3 as a downstream Fyn effector that cooperates with NF-κB, providing a mechanistic framework for studying kinase-associated neurodegeneration.

• Exendin-4 Workflows for Type 2 Diabetes Research

  2026-08-23

  Build more informative beta-cell, cAMP, insulin-sensitivity, and hepatic-steatosis assays with Exendin-4 (Exenatide). This practical guide connects controlled peptide workflows with a 2024 yeast-expression strategy, helping researchers distinguish assay optimization from translational production claims.

8041 records 1/537 page Next 12345 下5页 Last page